<DOC>
	<DOC>NCT02806479</DOC>
	<brief_summary>This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate</brief_summary>
	<brief_title>Hypertrophic Cardiomyopathy Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
	<criteria>Diagnosed HCM Documented history of sustained ventricular tachyarrhythmia or resuscitated sudden cardiac arrest Maximal left ventricular wall thickness of &gt; 30mm Extensive fibrosis on cardiac MRI (&gt;15% of total myocardial volume) &gt;7.5%/5year risk of sudden cardiac death as determined by HCM riskSCD age &lt; 18 years Pregnancy Atrial Fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>